Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sanjuliani AF, Francischetti EA, Genelhu de Abreu V, Ueleres Braga J
Effects of Moxonidine on the Sympathetic Nervous System, Blood Pressure, Plasma Renin Activity, Plasma Aldosterone, Leptin, and Metabolic Profile in Obese Hypertensive Patients
Journal of Clinical and Basic Cardiology 2004; 7 (1-4): 19-25

PDF    Summary    Overview   

This Image - Fig. 1: Moxonidine - Clinical evaluation Fig. 2: Moxonidine - Effect
Figure/Graphic 1: Moxonidine - Clinical evaluation
Study flow chart. Clinical evaluation: all visits; ambulatory blood pressure: visit 1 and 7; venous and arterial blood sample for assessment of catecholamines, insulin, glucose, leptin, plasma renin activity, plama aldosterone, total cholesterol, triglycerides, HDL-C and LDL-C: visit 1, 4 and 7.
 
Moxonidine - Clinical evaluation
Previous ImageNext Image   


Figure/Graphic 1: Moxonidine - Clinical evaluation
Study flow chart. Clinical evaluation: all visits; ambulatory blood pressure: visit 1 and 7; venous and arterial blood sample for assessment of catecholamines, insulin, glucose, leptin, plasma renin activity, plama aldosterone, total cholesterol, triglycerides, HDL-C and LDL-C: visit 1, 4 and 7.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung